Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Hargreaves, K., Dubner, R. A., Brown, F. J., Flores, C., & Joris, J. L. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,155

The PPARs: From Orphan Receptors to Drug Discovery

Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816

A method for measurement of analgesic activity on inflamed tissue.

Randall, L. O., & Selitto, J. J. (1957) · PubMed · Cited by 1,568

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α

Fu, J., Gaetani, S., Oveisi, F., Verme, J., Serrano, A., de Fonseca, F. D., Rosengarth, A., Luecke, H., Giacomo, B. D., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,113

Role of the Immune system in chronic pain

Marchand, F., Perretti, M., & McMahon, S. B. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1700 · Cited by 1,098

Control of pain initiation by endogenous cannabinoids

Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,069

The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide

Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882

Carrageenan-Induced Paw Edema in the Rat and Mouse

Morris, C. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-374-7:115 · Cited by 742

Design of a potent and selective inhibitor of the intermediate-conductance Ca 2+ -activated K + channel, IKCa1 : A potential immunosuppressant

Wulff, H., Miller, M. J., Hänsel, W., Grissmer, S., Cahalan, M. D., & Chandy, K. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8151 · Cited by 615

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Marzo, V. D., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,666

The Peroxisome Proliferator-Activated Receptor: A Family of Nuclear Receptors Role in Various Diseases

Tyagi, S., Gupta, P., Saini, A., Kaushal, C., & Sharma, S. (2011) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.90879 · Cited by 1,017

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors

O’Sullivan, S. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707423 · Cited by 509

The Endocannabinoid System and Pain

Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476

An update on PPAR activation by cannabinoids

O'Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 449

Intense exercise increases circulating endocannabinoid and BDNF levels in humans–possible implications for reward and depression

Heyman, E., Gamelin, F.-X., Goekint, M., Piscitelli, F., Roelands, B., Leclair, E., Di Marzo, V., & Meeusen, R. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.017 · Cited by 427

Cannabinoid CB 2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423

A neuroscientist's guide to lipidomics

Piomelli, D., Astarita, G., & Rapaka, R. S. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2233 · Cited by 399

The Lipid Messenger OEA Links Dietary Fat Intake to Satiety

Schwartz, G. J., Fu, J., Astarita, G., Li, X., Gaetani, S., Campolongo, P., Cuomo, V., & Piomelli, D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.005 · Cited by 370

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

Clapper, J. R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., Tontini, A., Sanchini, S., Sciolino, N. R., Spradley, J. M., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2632 · Cited by 346

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

Petrosino, S., & Marzo, V. D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13580 · Cited by 340

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside

Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305

The cannabinoid system and pain

Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 285

Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.

O'Sullivan, S., & Kendall, D. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.09.007 · Cited by 249

Peripheral gating of pain signals by endogenous lipid mediators

Piomelli, D., & Sasso, O. (2014) · Nature Neuroscience · doi:10.1038/nn.3612 · Cited by 240

Selective N -acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation

Solórzano, C., Zhu, C., Battista, N., Astarita, G., Lodola, A., Rivara, S., Mor, M., Russo, R., Maccarrone, M., Antonietti, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907417106 · Cited by 223

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

Anand, P., Whiteside, G. T., Fowler, C. J., & Hohmann, A. G. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 220

A fatty gut feeling

Piomelli, D. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.001 · Cited by 185

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice

Russo, R., LoVerme, J., La Rana, G., Compton, T. R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119941 · Cited by 182

Reduced Pain and Inflammation in Juvenile and Adult Rats Fed a Ketogenic Diet

Ruskin, D. N., Kawamura, M., & Masino, S. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008349 · Cited by 179

Endogenous Fatty Acid Ethanolamides Suppress Nicotine-Induced Activation of Mesolimbic Dopamine Neurons through Nuclear Receptors

Melis, M., Pillolla, G., Luchicchi, A., Muntoni, A. L., Yaşar, S., Goldberg, S. R., & Pistis, M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3221-08.2008 · Cited by 173

Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs

Berger, W. T., Ralph, B. P., Kaczocha, M., Sun, J. Y., Balius, T. E., Rizzo, R. C., Haj‐Dahmane, S., Ojima, I., & Deutsch, D. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050968 · Cited by 166

Fatty acid amide signaling molecules

Ezzili, C., Otrubova, K., & Boger, D. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.048 · Cited by 172

Palmitoylethanolamide in CNS health and disease

Raso, G. M., Russo, R., Calignano, A., & Meli, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.006 · Cited by 153

Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease

D’Agostino, G., Russo, R., Avagliano, C., Cristiano, C., Meli, R., & Calignano, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.25 · Cited by 149

Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia

Kaczocha, M., Rebecchi, M. J., Ralph, B. P., Teng, Y.-H. G., Berger, W. T., Galbavy, W., Elmes, M. W., Glaser, S. T., Wang, L., Rizzo, R. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094200 · Cited by 142

From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets

Pistis, M., & Melis, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980014 · Cited by 145

Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor-α Agonist, Modulates Carrageenan-Induced Paw Edema in Mice

D’Agostino, G., Rana, G. L., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G. M., Cuzzocrea, S., Verme, J. L., Piomelli, D., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123265 · Cited by 139

The emerging role of the endocannabinoid system in cardiovascular disease

Pacher, P., & Steffens, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0145-8 · Cited by 142

Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain

Hansen, H. S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.022 · Cited by 140

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia

D’Agostino, G., Rana, G. L., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G. M., Cuzzocrea, S., LoVerme, J., Piomelli, D., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.022 · Cited by 136

Minocycline Treatment Inhibits Microglial Activation and Alters Spinal Levels of Endocannabinoids in a Rat Model of Neuropathic Pain

Guasti, L., Richardson, D. S., Jhaveri, M. D., Eldeeb, K., Barrett, D. A., Elphick, M. R., Alexander, S. P. H., Kendall, D. A., Michael, G. J., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-35 · Cited by 133

The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation

Iannotti, F. A., & Vitale, R. M. (2021) · Cells · doi:10.3390/cells10030586 · Cited by 130

Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism

Mannelli, L. D. C., D’Agostino, G., Pacini, A., Russo, R., Zanardelli, M., Ghelardini, C., & Calignano, A. (2013) · Mediators of Inflammation · doi:10.1155/2013/328797 · Cited by 132

Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-α nuclear receptorsPreprint

Mazzola, C., Medalie, J., Scherma, M., Panlilio, L. V., Solinas, M., Tanda, G., Drago, F., Cadet, J. L., Goldberg, S. R., & Yaşar, S. (2009) · Learning & Memory · doi:10.1101/lm.1145209 · Cited by 134

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 130

Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain

Jhaveri, M. D., Richardson, D. S., Robinson, I., Garle, M. J., Patel, A., Sun, Y., Sagar, D. R., Bennett, A. J., Alexander, S. P. H., Kendall, D. A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.018 · Cited by 122

Harnessing the anti-inflammatory potential of palmitoylethanolamide

Alhouayek, M., & Muccioli, G. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.007 · Cited by 123

Protective role of palmitoylethanolamide in contact allergic dermatitis

Petrosino, S., Cristino, L., Karsak, M., Gaffal, E., Ueda, N., Tüting, T., Bisogno, T., Filippis, D. D., D’Amico, A., Saturnino, C., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02254.x · Cited by 120

The Basal Pharmacology of Palmitoylethanolamide

Rankin, L., & Fowler, C. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217942 · Cited by 123

Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction

Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106

Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase

Naidu, P. S., Kinsey, S. G., Guo, T. L., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164806 · Cited by 108

Lipidomic analysis of endocannabinoid metabolism in biological samples

Astarita, G., & Piomelli, D. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.01.008 · Cited by 108

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

Skaper, S. D., Facci, L., Fusco, M., della Valle, M. F., Zusso, M., Costa, B., & Giusti, P. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0191-7 · Cited by 110

The Role of PPAR Alpha in the Modulation of Innate Immunity

Grabacka, M., Pierzchalska, M., Plonka, P. M., & Pierzchalski, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910545 · Cited by 115

Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats

Fu, J., Kim, J., Oveisi, F., Astarita, G., & Piomelli, D. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00126.2008 · Cited by 106

Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism

Naughton, S., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2013) · International Journal of Endocrinology · doi:10.1155/2013/361895 · Cited by 109

Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models

Sasso, O., Moreno‐Sanz, G., Martucci, C., Realini, N., Dionisi, M., Mengatto, L., Duranti, A., Tarozzo, G., Tarzia, G., Mor, M., et al. (2012) · Pain · doi:10.1016/j.pain.2012.10.018 · Cited by 106

The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action

Fowler, C. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707379 · Cited by 104

Endocannabinoids: A unique opportunity to develop multitarget analgesics

Maione, S., Costa, B., & Marzo, V. D. (2013) · Pain · doi:10.1016/j.pain.2013.03.023 · Cited by 104

Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy

Citraro, R., Russo, E., Scicchitano, F., van Rijn, C. M., Cosco, D., Avagliano, C., Russo, R., D’Agostino, G., Petrosino, S., Guida, F., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.017 · Cited by 100

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide

Scuderi, C., Esposito, G., Blasio, A., Valenza, M., Arietti, P., Steardo, L., Carnuccio, R., Filippis, D. D., Petrosino, S., Iuvone, T., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01267.x · Cited by 100

Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease

Scuderi, C., Stecca, C., Valenza, M., Ratano, P., Bronzuoli, M. R., Bartoli, S., Steardo, L., Pompili, E., Fumagalli, L., Campolongo, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.376 · Cited by 100

Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats

Sayd, A., Antón, M., Alén, F., Caso, J. R., Pavon, J., Leza, J. C., de Fonseca, F. R., García‐Bueno, B., & Orío, L. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu111 · Cited by 102

Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia

Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 99

Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms

Cristiano, C., Pirozzi, C., Coretti, L., Cavaliere, G., Lama, A., Russo, R., Lembo, F., Mollica, M. P., Meli, R., Calignano, A., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.003 · Cited by 99

Intrathecal Rosiglitazone Acts at Peroxisome Proliferator–Activated Receptor-γ to Rapidly Inhibit Neuropathic Pain in Rats

Churi, S. B., Abdel‐Aleem, O. S., Tumber, K. K., Scuderi-Porter, H., & Taylor, B. K. (2008) · Journal of Pain · doi:10.1016/j.jpain.2008.02.002 · Cited by 95

Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity

Mannelli, L. D. C., Pacini, A., Corti, F., Boccella, S., Luongo, L., Esposito, E., Cuzzocrea, S., Maione, S., Calignano, A., & Ghelardini, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128080 · Cited by 91

Inhibition of fatty acid amide hydrolase produces PPAR‐α‐mediated analgesia in a rat model of inflammatory pain

Sagar, D. R., Kendall, D. A., & Chapman, V. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.335 · Cited by 89

The role of the endocannabinoid system in lipogenesis and fatty acid metabolism

Vettor, R., & Pagano, C. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.002 · Cited by 90

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse

Orío, L., Alén, F., Pavón, F. J., Serrano, A., & García‐Bueno, B. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00490 · Cited by 91

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice

Kinsey, S. G., Naidu, P. S., Cravatt, B. F., Dudley, D. T., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.022 · Cited by 87

Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs

Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., & Cuomo, V. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)85005-8 · Cited by 83

Proinflammatory Stimuli Control N-Acylphosphatidylethanolamine-Specific Phospholipase D Expression in Macrophages

Zhu, C., Solorzano, C., Sahar, S., Realini, N., Fung, E. S., Sassone‐Corsi, P., & Piomelli, D. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070201 · Cited by 86

N -Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition

Piomelli, D., Scalvini, L., Fotio, Y., Lodola, A., Spadoni, G., Tarzia, G., & Mor, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00191 · Cited by 81

N -Acylethanolamine Metabolism Interacts with Abscisic Acid Signaling in Arabidopsis thaliana Seedlings

Teaster, N. D., Motes, C. M., Tang, Y., Wiant, W. C., Cotter, M. Q., Wang, Y., Kilaru, A., Venables, B. J., Hasenstein, K. H., Gonzalez, G., et al. (2007) · The Plant Cell · doi:10.1105/tpc.106.048702 · Cited by 81

Microglia produce and hydrolyze palmitoylethanolamide

Muccioli, G. G., & Stella, N. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.015 · Cited by 83

Generation of N-Acylphosphatidylethanolamine by Members of the Phospholipase A/Acyltransferase (PLA/AT) Family

Uyama, T., Ikematsu, N., Inoue, M., Shinohara, N., Jin, X., Tsuboi, K., Tonai, T., Tokumura, A., & Ueda, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.368712 · Cited by 82

Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series

Hesselink, J. M. K., & Hekker (2012) · Journal of Pain Research · doi:10.2147/jpr.s32143 · Cited by 80

Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity

Ghafouri, N., Ghafouri, B., Larsson, B. K., Stensson, N., Fowler, C. J., & Gerdle, B. U. C. (2013) · Pain · doi:10.1016/j.pain.2013.05.002 · Cited by 78

Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments

Ford, A. C., Vanner, S. J., Kashyap, P., & Nasser, Y. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.045 · Cited by 87

Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma

de Oliveira, A. C. P., Bertollo, C. M., Rocha, L. T. S., Junior, E. B. D. N., Costa, K. A., & Coelho, M. M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.026 · Cited by 78

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 81

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models

Britti, D., Crupi, R., Impellizzeri, D., Gugliandolo, E., Fusco, R., Schievano, C., Morittu, V. M., Evangelista, M., Paola, R. D., & Cuzzocrea, S. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1151-z · Cited by 76

Palmitoylethanolamide Reduces Granuloma-Induced Hyperalgesia by Modulation of Mast Cell Activation in Rats

Filippis, D. D., Luongo, L., Cipriano, M., Palazzo, E., Cinelli, M. P., de Novellis, V., Maione, S., & Iuvone, T. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-3 · Cited by 76

Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

Karbarz, M. J., Luo, L., Chang, L., Tham, C.-S., Palmer, J. A., Wilson, S. J., Wennerholm, M. L., Brown, S. M., Scott, B. P., Apodaca, R. L., et al. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31818c7cbd · Cited by 74

A Second Generation of Carbamate‐Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo

Clapper, J. R., Vacondio, F., King, A. R., Duranti, A., Tontini, A., Silva, C., Sanchini, S., Tarzia, G., Mor, M., & Piomelli, D. (2009) · ChemMedChem · doi:10.1002/cmdc.200900210 · Cited by 76

Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms

Griggs, R. B., Donahue, R. R., Morgenweck, J., Grace, P. M., Sutton, A., Watkins, L. R., & Taylor, B. K. (2015) · Pain · doi:10.1097/01.j.pain.0000460333.79127.be · Cited by 75

Macrophage-derived lipid agonists of PPAR-αas intrinsic controllers of inflammation

Pontis, S., Ribeiro, A., Sasso, O., & Piomelli, D. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1092944 · Cited by 75

Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice

Russo, R., Caro, C. D., Avagliano, C., Cristiano, C., Rana, G. L., Raso, G. M., Canani, R. B., Meli, R., & Calignano, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.026 · Cited by 74

PPARs and pain

Okine, B. N., Gaspar, J. C., & Finn, D. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14339 · Cited by 70

Strategies to increase the activity of microglia as efficient protectors of the brain against infections

Nau, R., Ribes, S., Djukic, M., & Eiffert, H. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00138 · Cited by 73

The Nervous System and Metabolic Dysregulation: Emerging Evidence Converges on Ketogenic Diet Therapy

Ruskin, D. N., & Masino, S. A. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00033 · Cited by 67

A systematic review of the effects of oleoylethanolamide, a high‐affinity endogenous ligand of PPAR‐α, on the management and prevention of obesity

Tutunchi, H., Saghafi‐Asl, M., & Ostadrahimi, A. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13238 · Cited by 72

Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems

Russo, R., D’Agostino, G., Mattace Raso, G., Avagliano, C., Cristiano, C., Meli, R., & Calignano, A. (2012) · Peptides · doi:10.1016/j.peptides.2012.08.005 · Cited by 66

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy

Wallace, V. C. J., Segerdahl, A. R., Lambert, D. M., Vandevoorde, S., Blackbeard, J., Pheby, T., Hasnie, F., & Rice, A. S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707326 · Cited by 66

Activation of peroxisome proliferator-activated receptor γ in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema

Morgenweck, J., Abdel‐Aleem, O. S., McNamara, K. C., Donahue, R. R., Badr, M. Z., & Taylor, B. K. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.10.008 · Cited by 67

A Lipid Gate for the Peripheral Control of Pain

Piomelli, D., Hohmann, A. G., Seybold, V. S., & Hammock, B. D. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3475-14.2014 · Cited by 67

Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide

Bettoni, I., Comelli, F., Colombo, A., Bonfanti, P., & Costa, B. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010008 · Cited by 66

15d-Prostaglandin J2 Inhibits Inflammatory Hypernociception: Involvement of Peripheral Opioid Receptor

Napimoga, M. H., de Souza, G. R., Cunha, T. M., Ferrari, L. F., Clemente‐Napimoga, J. T., Parada, C. A., Verri, W. A., Jr., Cunha, F. Q., & Ferreira, S. H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.126045 · Cited by 66

Peroxisome Proliferator-Activated Receptor-γ Ligand, 15-Deoxy-Δ12,14-Prostaglandin J2, Reduces Neutrophil Migration via a Nitric Oxide Pathway

Napimoga, M. H., Vieira, S. M., Dal-Secco, D., de Freitas, A., Souto, F. O., Mestriner, F., Alves-Filho, J. C., Grespan, R., Kawai, T., Ferreira, S. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.609 · Cited by 67

Peroxisome Proliferator-Activated Receptor α Mediates Acute Effects of Palmitoylethanolamide on Sensory Neurons

Khasabova, I. A., Xiong, Y., Coicou, L. G., Piomelli, D., & Seybold, V. S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0130-12.2012 · Cited by 64

Rapid pain modulation with nuclear receptor ligands

Fehrenbacher, J. C., LoVerme, J., Clarke, W. P., Hargreaves, K., Piomelli, D., & Taylor, B. K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.019 · Cited by 64

Localization of the Endocannabinoid-Degrading Enzyme Fatty Acid Amide Hydrolase in Rat Dorsal Root Ganglion Cells and Its Regulation after Peripheral Nerve Injury

Lever, I. J., Robinson, M., Cibelli, M., Paule, C. C., Sántha, P., Yee, L., Hunt, S. P., Cravatt, B. F., Elphick, M. R., Nagy, I., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4071-08.2009 · Cited by 63

Lack of Sterol Regulatory Element Binding Factor-1c Imposes Glial Fatty Acid Utilization Leading to Peripheral Neuropathy

Cermenati, G., Audano, M., Giatti, S., Carozzi, V., Porretta‐Serapiglia, C., Pettinato, E., Ferri, C., D’Antonio, M., Fabiani, E. D., Crestani, M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.016 · Cited by 61

Implication of allopregnanolone in the antinociceptive effect of N -palmitoylethanolamide in acute or persistent pain

Sasso, O., Russo, R., Vitiello, S., Raso, G. M., D’Agostino, G., Iacono, A., Rana, G. L., Vallée, M., Cuzzocrea, S., Piazza, P. V., et al. (2011) · Pain · doi:10.1016/j.pain.2011.08.010 · Cited by 62

Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats

Martinez, A. A., Morgese, M. G., Pisanu, A., Macheda, T., Paquette, M. A., Seillier, A., Cassano, T., Carta, A. R., & Giuffrida, A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.024 · Cited by 62

Advances in the discovery of N-acylethanolamine acid amidase inhibitors

Bandiera, T., Ponzano, S., & Piomelli, D. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.011 · Cited by 60

Actions of 3-methyl-N-oleoyldopamine, 4-methyl-N-oleoyldopamine and N-oleoylethanolamide on the rat TRPV1 receptor in vitro and in vivo

Almási, R., Szőke, É., Bölcskei, K., Varga, A., Riedl, Z., Zoltán, S., Szolcsányi, J., & Pethö, G. (2008) · Life Sciences · doi:10.1016/j.lfs.2007.12.022 · Cited by 59

Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system

Starowicz, K., & Przewłocka, B. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0392 · Cited by 60

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.

Piomelli, D., LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A. G., & Calignano, A. (2006) · eScholarship (California Digital Library)

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-. J Pharmacol Exp Ther 319:1051–1061

LoVerme, J., Russo, R., Rana, G. L., Fu, J., Farthing, J. N., Meli, R., Hohmann, A. G., Calignano, A., & Piomelli, D. (2006)

A role for PPAR-alpha in the Central Nervous System in pain and inflammation control

D’Agostino, G. (2010)

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia

D’Agostino, G., Rana, G. L., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G. M., Cuzzocrea, S., LoVerme, J., Piomelli, D., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.022 · Cited by 136

A role for PPARα in the medial prefrontal cortex in formalin‐evoked nociceptive responding in rats

Okine, B., Rea, K., Olango, W., Price, J., Herdman, S., Madasu, M., Roche, M., & Finn, D. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12540 · Cited by 29